Goldman Sachs analyst Salveen Richter initiates coverage on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) with a Neutral rating and a price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage